Literature DB >> 11680936

Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.

Y Ogata1, K Miura, A Ohkita, H Nagase, K Shirouzu.   

Abstract

We have evaluated the degree of MMP-9 and TIMP-1 messenger RNA (mRNA) expressions according to cell types in tumor tissues, and evaluated the implication of balance between the MMP-9 mRNA and the TIMP-1 mRNA expression in liver metastasis using orthotopic-implanted colon cancer in nude mouse, and also in 47 patients with colorectal cancer. The grade of MMP-9 or TIMP-1 mRNA expression was classified into 4 categories according to positive cell ratio. A higher grade of MMP-9 mRNA expression in tumor cells was correlated with liver metastasis in the experimental colon cancer, but was not statistically correlated in the clinical colorectal cancer. In contrast, the expression of TIMP-1 mRNA in the stromal cells of human colorectal cancer was correlated with liver metastasis. In both experimental and clinical colorectal cancer, a balance between the expression of MMP-9 mRNA and that of TIMP-1 mRNA was correlated with the occurrence of liver metastasis. The imbalance of MMP-9 dominance in tumor cells was implicated in liver metastasis. However, there was no significant relationship between the incidence of liver metastasis and the expression patterns of MMP-9 and TIMP-1 mRNA in the stromal cells. These results suggest that the balance between the expressions of MMP-9 and TIMP-1 in the tumor cells is more closely related to tumor biological behavior rather than the balance in the stromal cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680936     DOI: 10.2739/kurumemedj.48.211

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  10 in total

Review 1.  Implication of gelatinases in retinoblastoma development.

Authors:  Adina Zamfir-Chiru-Anton; Cristian Gheorghe Dan
Journal:  Rom J Ophthalmol       Date:  2016 Apr-Jun

2.  Expression of MMP-2 and MMP-9 in retinoblastoma and their significance.

Authors:  Hua Long; Bo Zhou; Fa-Gang Jiang
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

3.  Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.

Authors:  Wei-Jian Guo; Jie Li; Wan-Long Ling; Yong-Rui Bai; Wen-Zhu Zhang; Yu-Fan Cheng; Wen-Hua Gu; Jun-Yan Zhuang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  Resistance of MMP9 and TIMP1 to endotoxin tolerance.

Authors:  Manoj Muthukuru; Christopher W Cutler
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

5.  The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Matthew T Hardison; F Shawn Galin; Christopher E Calderon; Uros V Djekic; Suzanne B Parker; Keith M Wille; Patricia L Jackson; Robert A Oster; K Randall Young; J Edwin Blalock; Amit Gaggar
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

6.  The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.

Authors:  Barbara Mroczko; Magdalena Groblewska; Bogna Okulczyk; Bogusław Kedra; Maciej Szmitkowski
Journal:  Int J Colorectal Dis       Date:  2010-06-17       Impact factor: 2.571

7.  Determination of oral bioavailability of fusaric acid in male Sprague-Dawley rats.

Authors:  Brendan C Stack; John Ye; Rebecca Willis; Martha Hubbard; Howard P Hendrickson
Journal:  Drugs R D       Date:  2014-06

8.  Molecular mechanisms of astragaloside‑IV in cancer therapy (Review).

Authors:  Tianqi Chen; Peiying Yang; Yingjie Jia
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

9.  The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.

Authors:  Hongsheng Lu; Zhaohui Yang; Hui Zhang; Meifu Gan; Tao Zhou; Siling Wang
Journal:  Exp Ther Med       Date:  2012-12-17       Impact factor: 2.447

10.  Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2.

Authors:  E Thomas Danielsen; Anders Krüger Olsen; Mehmet Coskun; Annika W Nonboe; Sylvester Larsen; Katja Dahlgaard; Eric Paul Bennett; Cathy Mitchelmore; Lotte Katrine Vogel; Jesper Thorvald Troelsen
Journal:  Sci Rep       Date:  2018-08-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.